TCIM
AXSM icon

TIAA CREF Investment Management’s Axsome Therapeutics AXSM Stock Holding History

TIAA CREF Investment Management’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-31,730
Closed -$124K – 3139
2017
Q1 		$124K Sell
31,730
-4,050
-11% -$19.4K ﹤0.01% 3030
2016
Q4 		$242K Buy
35,780
+3,038
+9% +$21.3K ﹤0.01% 3014
2016
Q3 		$258 Hold
32,742
– – ﹤0.01% 3022
2016
Q2 		$247K Buy
+32,742
New +$302K ﹤0.01% 3064

Other funds holding AXSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $581M AUM 108.65% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
SCM
Sio Capital Management New York $694M AUM 79.73% 1-Year Est. Return
OPPM
Opus Point Partners Management New York $46.9M AUM 7.48% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $86.6B AUM 38.74% 1-Year Est. Return